Full-Time

Head of Research Portfolio Strategy

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$208.2k - $327.1k/yr

+ Short-term Incentives + Long-term Incentives

Expert

Boston, MA, USA

Category
Lab & Research
Interdisciplinary Research
Life Sciences
Requirements
  • Expected 15 years related experience in the pharmaceutical industry, with working knowledge of research and development and commercial operations.
  • Expected 10 years drug development experience in pharmaceutical/biotechnology with interdisciplinary global experience with complex projects including program leadership, strategy and execution and matrix team management.
  • Proven ability to respectfully challenge and influence senior leaders
  • Expertise in competitive portfolio landscapes in Takeda therapeutic areas
  • Demonstrated leadership skills with the ability to provide strategic direction and drive results.
  • Excellent project management and organizational skills.
  • Strong communication and interpersonal skills to effectively collaborate with cross-functional teams.
Responsibilities
  • Develops and implements a comprehensive portfolio management strategy for the Research pipeline, aligning it with the company's overall business objectives.
  • Actively contributes to real-time and effective portfolio prioritization, decision making and key portfolio analytics to support individual asset and portfolio-level decision making, including at senior governance bodies.
  • Ensures alignment to Research strategy and priorities through strong partnerships with Research Leadership Team members and other senior leaders.
  • Leads team of portfolio managers and analysts, providing guidance, mentorship, and support to ensure the successful execution of portfolio management processes.
  • Leads strategic initiatives independently and under the direction of the Head of Research Strategy & Operations to improve the portfolio management, portfolio linkage and prioritization methodology, as well as identifies internal strategic imperatives and develops mechanisms to effectively respond to evolving business needs.
  • Accountable to setting and meeting Research key performance indicators (KPIs)
  • Collaborates with research scientists, project leaders, and cross-functional teams to evaluate and prioritize research projects based on strategic fit, scientific merit, market potential, and resource availability.
  • Ensures Takeda Research leverages the most effective AI/digital tools that enable leadership portfolio decision making.
  • Conducts regular portfolio reviews to assess project progress, identify risks and opportunities, and make data-driven recommendations for portfolio optimization.
  • Conducts regular competitive assessments of external landscape to contextualize portfolio opportunities, risks, and long-term strategy.
  • Collaborates closely with Therapeutic Area Unit (TAU) Portfolio Strategy leaders to maintain links between research area strategies across discovery and clinical research.
  • Develops and maintains portfolio management tools, methodologies, and dashboards to facilitate effective decision-making and communication across the organization.
  • Collaborates with finance and resource management teams to ensure optimal allocation of resources, including budget, personnel, and infrastructure, to support the Research portfolio.
  • Monitors and analyzes external market trends, competitive landscape, and regulatory developments to inform portfolio management strategies and identify potential partnerships or licensing opportunities.
  • Fosters a culture of innovation and continuous improvement within the portfolio management team, promoting best practices and knowledge sharing.
  • Collaborates with senior leadership to provide regular updates on portfolio performance, key milestones, and strategic recommendations.
Desired Qualifications
  • Advanced degree (Ph.D., M.S., or equivalent) in a scientific discipline preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline that includes 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to support its operations. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its research and product development. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and public health. The company's goal is to innovate and provide life-changing treatments while also addressing environmental challenges.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...